Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Leuk Res ; 76: 11-14, 2019 01.
Article in English | MEDLINE | ID: mdl-30472478

ABSTRACT

In this work, we investigated the stability of arsenic trioxide (ATO) used in leukemia treatment, encapsulated with nanoliposome, with the aid of ultrasound treatment. Stability studies of As species were followed by liquid chromatography-inductively coupled plasma mass spectrometry (LC-ICP-MS), allowing for the detection of the conversion of low amounts of As(III) to As(V) or the formation of other As species. The influence of storage temperature and time on ATO was evaluated. Low amounts of As(III) to As(V) conversions were observed when the As encapsulated with nanoliposome was incubated at 25 °C and 40 °C. However, As(III) was stable if the solution was maintained at 5 °C, even after 90 days. No formation of other As species was observed, indicating good stability of the encapsulated ATO. Next step of the work will focus on spray drying of ATO nanoliposomes-encapsuleted with the aim of long term stability of As.


Subject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Agents/chemistry , Arsenic Trioxide/administration & dosage , Arsenic Trioxide/chemistry , Antineoplastic Agents/pharmacology , Arsenic Trioxide/pharmacology , Cell Line, Tumor , Chromatography, Liquid , Drug Stability , Humans , Leukemia, Promyelocytic, Acute/drug therapy , Liposomes , Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL
...